Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Summer 2013 - Vaccines
Download Issue
Share
Up Front
Publisher's Corner
The New Age of Vaccines
By Patrick M. Schmidt
Features
Choosing Influenza Vaccines
By
Ronale Tucker Rhodes, MS
The Role of Vaccines in Global Disease Prevention
By
Trudie Mitschang
Myths and Facts: Bird Flu
By
Ronale Tucker Rhodes, MS
The Childhood Vaccine Series: Balancing Health, Safety and Stakeholder Concerns
By
Hillary Johnson, MHS
BioTrends Watch
Washington Report
24 States Have Selected Benchmark Insurance Plans
Feds to Provide 100 Percent Funding for New Medicaid Beneficiaries
CMS Reverses Decision to Cut Medicare Advantage Rates
Congress to Review Advance-Care Planning Legislation
ACA Helps 105 Million Americans Receive Free Preventive Care
Government Partners with States to Offer Health Insurance Exchanges
Industry News
Risk of PML with TYSABRI Incorrectly Reported
Grifols Launches New IVIG Alzheimer's Trial
Shingles Vaccine May Be Safe for Autoimmune Disease Patients
New Boxed Warning Added to Immune Globulin Products
New Method Developed for Forecasting Flu Outbreaks
FDA Orders New Boxed Warning for Hydroxyethyl Starch
FDA Grants Expanded Indication Approval for CSL Behring's Corifact
HIV Vaccine Update
Hepatitis B Exceeds Two Million in U.S.
New "FLAB Jab" Reduces Body Weight
Short Course of IVIG Slows Early Alzheimer's
BioFocus
Industry Insight
Hydroxyethyl Starch in Critically Ill Patients: The Verdict Is In
By Keith Berman, MPH, MBA
Patient Profile
Lyme Disease: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Lyme Disease: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Use of Hydroxyethyl Starch in Sepsis Patients Increases Risk of Renal Replacement Therapy, Transfusion, Serious Adverse Events
Intravenous Immunoglobulin Sharply Reduces Relapse Rate in a Series of Patients with Neuromyelitis Optica
IVIG and Rituximab Desensitization for Renal Transplantation Is Cost-Effective and May Improve Survival